LANSING, Mich. (WOOD) — Pfizer is sinking $750 million into its plant near Kalamazoo and preparing to add some 300 jobs as it expands.

Pfizer leaders, local and state senators and Gov. Gretchen Whitmer gathered in Lansing Monday to announce the expansion at the plant in Portage.

“Building on the profound legacy and impact in Kalamazoo, today marks a new chapter not just for us at Pfizer, but also for U.S. manufacturing, the community in Michigan and all the patients around the world who count on us,” Pfizer Vice President and Site Leader David Breen said at the news conference.

“In the last five years, Pfizer has invested more than $1 billion in the modular aseptic processing — or MAP — program in Kalamazoo, establishing the facility as one of the most technologically advanced sterile injectable facilities in the world,” Breen continued.

Breen said the investments will help ensure uninterrupted supply for medicines and vaccines, including vaccines that take advantage of the new mRNA technology used in its COVID-19 vaccine.

“This investment will make sterile injectables easier to use by converting the vaccines to prefilled syringes. Making it more efficient and convenient for consumers,” Breen said.

Construction is underway on an expansion to Pfizer's Portage facility. (Dec. 5, 2022)
Construction is underway on an expansion to Pfizer’s Portage facility.

Pfizer has not said where the newest expansion will be located on the property or when construction for the project will begin.

“It will go within the existing footprint that we have, it will be a build-out to install the internal capabilities that we need for that aseptic manufacturing, which is sterile injectable manufacturing,” Breen said.

The mayor of Portage, Patricia Randall, said the city is working to expand housing and meet other needs as the area works to keep up with economic growth. 

“It’s really nice to know that they are growing and doing so well here and able to attract and retain the talent that is needed for these jobs,” Randall said.

Pfizer in June announced a $120 million investment in the plant with the goal of ramping up production of its COVID-19 treatment pill.

“Let’s think about what this investment means: It means more opportunity for Michiganders in West Michigan to support themselves and raise their families,” Whitmer said. “It means expanded capacity to make more lifesaving vaccines and treatments. It means a bold investment in our future, creating space for some of the best and brightest scientists, researchers and doctors in the world to innovate. It means more moonshots.”

About 3,000 people already work at the Portage plant, which spans 400,000 square feet and has an estimated annual impact of $3 billion on the local economy.